Trial Profile
A double-blind, placebo-controlled study to assess the effect of gemfibrozil co-administration on the pharmacokinetics and pharmacodynamics of mitiglinide in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Mar 2010
Price :
$35
*
At a glance
- Drugs Mitiglinide (Primary) ; Gemfibrozil
- Indications Lipid metabolism disorders; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Elixir Pharmaceuticals
- 11 Dec 2007 New trial record.